Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.29 USD | -1.74% | -6.69% | -21.10% |
Jun. 05 | Transcript : OptimizeRx Corporation - Shareholder/Analyst Call | |
May. 14 | Transcript : OptimizeRx Corporation, Q1 2024 Earnings Call, May 14, 2024 |
Business Summary
Number of employees: 136
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Intelligent Technology Platform
100.0
%
| 62 | 100.0 % | 72 | 100.0 % | +14.53% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 62 | 100.0 % | 72 | 100.0 % | +14.53% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Edward Stelmakh
DFI | Director of Finance/CFO | 58 | 21-10-10 |
President | 46 | 19-04-28 | |
Compliance Officer | 60 | 21-02-07 | |
Andrew D'Silva
IRC | Investor Relations Contact | - | - |
Theresa Greco
PRN | Corporate Officer/Principal | - | 23-10-24 |
Sheryl Kearney
HRO | Human Resources Officer | - | 19-11-30 |
Sales & Marketing | 58 | 08-01-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gregory Wasson
BRD | Director/Board Member | 65 | 20-07-20 |
Catherine Klema
BRD | Director/Board Member | 65 | Jan. 23 |
Patrick Spangler
BRD | Director/Board Member | 68 | 18-03-26 |
Ellen Vos
CHM | Chairman | 68 | 15-09-23 |
Jim Lang
BRD | Director/Board Member | 59 | 17-01-11 |
Will Febbo
CEO | Chief Executive Officer | 55 | 16-02-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 20,011,220 | 15,960,156 ( 79.76 %) | 1,741,397 ( 8.702 %) | 79.76 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.10% | 206M | |
+27.45% | 452B | |
+33.20% | 279B | |
+11.91% | 144B | |
+7.98% | 93.32B | |
+26.24% | 91.51B | |
+70.03% | 63.37B | |
+15.32% | 46.64B | |
+25.04% | 36.22B | |
-11.83% | 31.47B |
- Stock Market
- Equities
- OPRX Stock
- Company OptimizeRx Corporation